Health Advance Inc. (HADV)
- Previous Close
0.0008 - Open
0.0008 - Bid 0.0008 x --
- Ask 0.0009 x --
- Day's Range
0.0008 - 0.0008 - 52 Week Range
0.0007 - 0.0073 - Volume
130,000 - Avg. Volume
3,007,822 - Market Cap (intraday)
183,932 - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Health Advance Inc., a development stage company, operates as an on-line retailer of home medical products in Canada and the United States. It intends to offers aids to daily living, ambulatory, bath safety, core wound care, diabetic, enteral nutrition-feeding, home diagnostics, incontinence, orthopedic, ostomy, pain management, professional use and diagnostic, respiratory, tracheostomy care, specialty wound care, and women-infant products. The company's product portfolio would also include bed accessories, catheters, diagnostic equipment, lift chairs/geri chairs, IV supplies, needles/syringes, patient lifts and acc, personal protection products/gloves, scooters and accessories, seating/cushions, specialty medical equipment and accessories, urological/collection devices, wheelchairs accessories. It focuses on operating leadingmedicalproducts.com, an e-commerce site for the retail community and health care community. The company intends to serve health care professionals, medical distributors, and consumers. Health Advance Inc. was founded in 2010 and is based in Las Vegas, Nevada.
www.healthadvanceinc.comRecent News: HADV
View MorePerformance Overview: HADV
Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HADV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HADV
View MoreValuation Measures
Market Cap
173.71k
Enterprise Value
173.71k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-32.22k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.53k
Total Debt/Equity (mrq)
134.85%
Levered Free Cash Flow (ttm)
--